Characterization of a leukocidin identified in Staphylococcus pseudintermedius

Area of Science:

• Veterinary Microbiology
• Immunology
• Molecular Biology

Background:

• Staphylococcus pseudintermedius causes common canine skin infections (pyoderma).
• Staphylococcal leukocidins are toxins that target and impair the host immune system.
• Understanding these toxins is crucial for developing effective treatments and preventatives for canine infections.

Purpose of the Study:

• To identify and characterize novel leukocidins from Staphylococcus pseudintermedius.
• To investigate the cytotoxic effects of these identified leukocidins on canine immune cells.
• To evaluate the potential of leukocidins as vaccine targets for canine pyoderma.

Main Methods:

• Genome sequencing and secretome analysis of S. pseudintermedius.
• Liquid chromatography-mass spectrometry to identify proteins.
• Phylogenetic analysis to compare identified leukocidins with known ones.
• Recombinant protein expression and functional assays (flow cytometry) to determine cytotoxicity.
• In vivo studies using canine anti-Luk-I antibodies.

Main Results:

• Two novel leukocidin components, LukS-I and LukF-I, were identified in S. pseudintermedius.
• LukS-I and LukF-I exhibited potent cytotoxic effects on canine polymorphonuclear leukocytes specifically when combined.
• Mutant versions of the leukocidins were non-cytotoxic.
• Antibodies against Luk-I reduced the cytotoxic activity of native canine leukotoxin.

Conclusions:

• The S. pseudintermedius leukotoxin, Luk-I, is a key virulence factor contributing to canine pyoderma.
• LukS-I and LukF-I act synergistically to induce cytotoxicity.
• Luk-I represents a promising target for vaccine development against canine S. pseudintermedius infections.